In 2015, the American Diabetes Association (ADA) estimated that the annual total cost of diabetic patients is $223.5 billion in the US alone. The global annual cost is estimated at $465 billion and is expected to reach $510 billion a year by 2030.

1. Follow Us:
Stem Cell Therapy for Diabetes and Related
Conditions Is Expected To Reach $510 Billion
A Year By 2030
The stem cell therapy for diabetes and related conditions pipeline analysis report
includes ongoing clinical and non-clinical trends in the global stem cell therapy for
diabetes and related conditions treatment. Most of the pipeline therapeutics are in early
stage of development, a long-lasting and less frequent dose can impact overall diabetes
market.
In 2015, the American Diabetes Association (ADA) estimated that the annual total cost
of diabetic patients is $223.5 billion in the US alone. The global annual cost is estimated
at $465 billion and is expected to reach $510 billion a year by 2030.
The report covers the present scenario and the growth prospects of the stem cell
therapy for diabetes and related conditions. The report presents a detailed picture of the
market by way of study, synthesis, and summation of data from multiple sources.
Request A Sample Copy Of This Report:
https://www.radiantinsights.com/research/stem-cell-therapy-for-diabetes-
and-related-conditions-a-pipeline-analysis-report/request-sample
“In 2015, the American Diabetes Association (ADA)
estimated that the annual total cost of diabetic
patients is $223.5 billion in the US alone. The global
annual cost is estimated at $465 billion and is
expected to reach $510 billion a year by 2030.”

2. Follow Us:
Key questions answered in this report
• How will the market evolve during the forecast period?
• What are the major parameters impacting the market?
• What are the key market trends?
• What are the challenges to market growth?
• Who are the key companies in this market space?
The report covers the present scenario and the growth prospects of the stem cell
therapy for diabetes and related conditions. The report presents a detailed picture of the
market by way of study, synthesis, and summation of data from multiple sources.
Radiant Insights Stem Cell Therapy for Diabetes and Related Conditions - A Pipeline
Analysis Report, has been prepared based on an in-depth market analysis with inputs
from industry experts. The report covers the market landscape and its growth prospects
during the forecast period. The report also includes a discussion of the key companies
operating in this market.
Major companies
• Athersys
• Mesoblast
• Caladrius Biosciences
• Sanofi
• Novo Nordisk
Browse Full Research Report:
https://www.radiantinsights.com/research/stem-cell-therapy-for-diabetes-
and-related-conditions-a-pipeline-analysis-report
Table of Contents:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Pipeline landscape
PART 07: Market segmentation by therapy
• Immunoglobulin therapy
• Antibiotics
• Others
PART 08: Geographical segmentation

3. Follow Us:
• PIDDs treatment market in Americas
• PIDDs treatment market in EMEA
• PIDDs treatment market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
List of Exhibits
• Exhibit 01: Features of PIDDs
• Exhibit 02: Signs and symptoms of PI
• Exhibit 03: PIDDs classification based on affected immune system
• Exhibit 04: Diagnosis and treatment of PI
• Exhibit 05: Global PIDDs treatment market 2016-2021 ($ millions)
• Exhibit 06: Opportunity analysis of global PIDDs treatment market
• Exhibit 07: Five forces analysis
• Exhibit 08: Pipeline analysis of vendors in global PIDDs treatment market
• Exhibit 09: Key clinical trials
• Exhibit 10: Market segmentation by therapy
• Exhibit 11: Global PIDDs treatment market by immunoglobulin therapy 2016-2021 ($
millions)
• Exhibit 12: Global PIDDs treatment market by antibiotics 2016-2021 ($ millions)
• Exhibit 13: Antibiotic prophylaxis regimens in several PIDDs
• Exhibit 14: Global PIDDs treatment market by others 2016-2021 ($ millions)
• Exhibit 15: Segmentation of global PIDDs treatment market by geography 2016 and
2021
• Exhibit 16: Global PIDDs treatment market revenue by geography 2016-2021 ($
millions)
• Exhibit 17: Market scenario in Americas
• Exhibit 18: PIDDs treatment market in Americas 2016-2021 ($ millions)
• Exhibit 19: Market scenario in EMEA
• Exhibit 20: PIDDs treatment market in EMEA 2016-2021 ($ millions)
• Exhibit 21: Market scenario in APAC
• Exhibit 22: PIDDs treatment market in APAC 2016-2021 ($ millions)
• Exhibit 23: Fractionation capacities of key vendors
• Exhibit 24: Various side effects associated with immunoglobulin therapy
• Exhibit 25: Factors contributing to overall cost of production for IVIG
• Exhibit 26: Detailed information regarding processes required for TGA approval
• Exhibit 27: Fractionating capacities globally in 2007 and 2012
• Exhibit 28: Competitive structure analysis of global PIDDs treatment market 2016
• Exhibit 29: Competitive factors of global PIDDs treatment market
See More Reports of This Category by Radiant Insights:
https://www.radiantinsights.com/catalog/healthcare

4. Follow Us:
About Radiant Insights, Inc:
Radiant Insights is a platform for companies looking to meet their market
research and business intelligence requirements. We assist and facilitate
organizations and individuals procure market research reports, helping them in
the decision making process. We have a comprehensive collection of reports,
covering over 40 key industries and a host of micro markets. In addition to over
extensive database of reports, our experienced research coordinators also offer
a host of ancillary services such as, research partnerships/ tie-ups and
customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc.201 Spear St #1100, Suite #3036San Francisco, CA 94105
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Web: http://www.radiantinsights.com/